Dr Kelly Goldsmith

Dr Kelly Goldsmith is Professor of Paediatrics at Emory University School of Medicine, Atlanta and Curing Kids Cancer Endowed Chair of Paediatric Oncology.

She serves as clinical director of the Neuroblastoma Program and the Aflac Precision Medicine Program at the Children’s Healthcare of Atlanta. She is also co-leader of the Discovery and Developmental Therapeutics Research program at the NCI designated Winship Cancer Institute at Emory University. Nationally, Dr. Goldsmith is vice chair of the Childrens Oncology Group (COG) Neuroblastoma Biology Committee and a member of the NIH/NCI/CCTN Paediatric Adolescent and Solid Tumour Steering Committee, which addresses the design, prioritization, and evaluation of concepts for large clinical trials in solid tumours of adolescents and children in the U.S.

Goldsmith has co-chaired several national clinical trials to evaluate novel treatments for patients with neuroblastoma, including studies that involve immunotherapy and precision medicine approaches. Goldsmith’s laboratory research focuses on defining molecular mechanisms of chemotherapy resistance in neuroblastoma in order to translate novel therapeutics into early phase clinical trials for this highly aggressive disease.